Get started
DR. REDDY S LABORATORIESDR. REDDY S LABORATORIESDR. REDDY S LABORATORIES

DR. REDDY S LABORATORIES

No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals Forecast Options

DRREDDY chart


Full chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.11 T‬INR
Dividend yield (indicated)
0.60%
Price to earnings Ratio (TTM)
19.95
Basic EPS (TTM)
333.85INR
Net income (FY)
‪55.68 B‬INR
Revenue (FY)
‪279.16 B‬INR
Shares float
‪121.79 M‬
Beta (1Y)
0.85

About DR. REDDY S LABORATORIES


Sector
Health Technology
CEO
Erez Israeli
Headquarters
Hyderabad
Website
drreddys.com
Employees (FY)
‪27.05 K‬
Founded
1984
ISIN
INE089A01023
FIGI
BBG000CQND59
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

News



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of DRREDDY is 6,567.80 INR — it has decreased by −0.96% in the past 24 hours. Watch DR. REDDY S LABORATORIES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange DR. REDDY S LABORATORIES stocks are traded under the ticker DRREDDY.
DRREDDY stock has fallen by −1.40% compared to the previous week, the month change is a −3.95% fall, over the last year DR. REDDY S LABORATORIES has showed a 12.83% increase.
We've gathered analysts' opinions on DR. REDDY S LABORATORIES future price: according to them, DRREDDY price has a max estimate of 8,010.00 INR and a min estimate of 4,705.00 INR. Watch DRREDDY chart and read a more detailed DR. REDDY S LABORATORIES stock forecast: see what analysts think of DR. REDDY S LABORATORIES and suggest that you do with its stocks.
DRREDDY reached its all-time high on Aug 21, 2024 with the price of 7,107.45 INR, and its all-time low was 36.00 INR and was reached on Dec 10, 1996. View more price dynamics on DRREDDY chart.
See other stocks reaching their highest and lowest prices.
DRREDDY stock is 1.79% volatile and has beta coefficient of 0.85. Track DR. REDDY S LABORATORIES stock price on the chart and check out the list of the most volatile stocks — is DR. REDDY S LABORATORIES there?
Today DR. REDDY S LABORATORIES has the market capitalization of ‪1.10 T‬, it has decreased by −4.72% over the last week.
Yes, you can track DR. REDDY S LABORATORIES financials in yearly and quarterly reports right on TradingView.
DR. REDDY S LABORATORIES is going to release the next earnings report on Oct 25, 2024. Keep track of upcoming events with our Earnings Calendar.
DRREDDY earnings for the last quarter are 83.46 INR per share, whereas the estimation was 80.31 INR resulting in a 3.92% surprise. The estimated earnings for the next quarter are 83.25 INR per share. See more details about DR. REDDY S LABORATORIES earnings.
DR. REDDY S LABORATORIES revenue for the last quarter amounts to ‪76.73 B‬ INR, despite the estimated figure of ‪73.15 B‬ INR. In the next quarter, revenue is expected to reach ‪77.59 B‬ INR.
DRREDDY net income for the last quarter is ‪13.92 B‬ INR, while the quarter before that showed ‪13.07 B‬ INR of net income which accounts for 6.50% change. Track more DR. REDDY S LABORATORIES financial stats to get the full picture.
Yes, DRREDDY dividends are paid annually. The last dividend per share was 40.00 INR. As of today, Dividend Yield (TTM)% is 0.60%. Tracking DR. REDDY S LABORATORIES dividends might help you take more informed decisions.
DR. REDDY S LABORATORIES dividend yield was 0.65% in 2023, and payout ratio reached 11.95%. The year before the numbers were 0.87% and 14.74% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 19, 2024, the company has ‪27.05 K‬ employees. See our rating of the largest employees — is DR. REDDY S LABORATORIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. REDDY S LABORATORIES EBITDA is ‪77.77 B‬ INR, and current EBITDA margin is 28.20%. See more stats in DR. REDDY S LABORATORIES financial statements.
Like other stocks, DRREDDY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. REDDY S LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR. REDDY S LABORATORIES technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR. REDDY S LABORATORIES stock shows the buy signal. See more of DR. REDDY S LABORATORIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.